RECRUITING

Neuronal Effects of Exercise in Schizophrenia

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study plans to learn more about how common drugs prescribed to individuals with schizophrenia contribute to weight gain, as well as how exercise and diet impact appetite and the brain's response to food. In this study, the investigators will be evaluating how participants' brains respond to food images as well as asking questions about their food preferences and intake and clinical symptoms. The investigators may also ask participants to complete an exercise or diet intervention to see how this changes brain responses or food preferences.

Official Title

Neuronal Effects of Exercise in Schizophrenia

Quick Facts

Study Start:2014-08
Study Completion:2025-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02455193

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years to 70 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of schizophrenia or schizoaffective disorder
  2. * Between 21 and 70 years of age
  3. * Currently prescribed either olanzapine, risperidone, clozapine, or haloperidol, OR not currently being treated with any neuroleptic medications
  4. * Weight stable within 5 percent for the last 6 months
  1. * Pregnancy
  2. * Substance abuse
  3. * Significant endocrine/metabolic disease (e.g., uncontrolled hypertension, severe hypertriglyceridemia)
  4. * MRI-specific exclusion criteria (e.g., claustrophobia, metal in the body)

Contacts and Locations

Study Contact

Kristina T Legget, Ph.D.
CONTACT
303-724-5809
kristina.legget@ucdenver.edu

Principal Investigator

Jason Tregellas, Ph.D.
PRINCIPAL_INVESTIGATOR
University of Colorado, Denver

Study Locations (Sites)

University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045
United States

Collaborators and Investigators

Sponsor: University of Colorado, Denver

  • Jason Tregellas, Ph.D., PRINCIPAL_INVESTIGATOR, University of Colorado, Denver

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2014-08
Study Completion Date2025-07

Study Record Updates

Study Start Date2014-08
Study Completion Date2025-07

Terms related to this study

Additional Relevant MeSH Terms

  • Schizophrenia